Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Paolo Dei Tos

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Seminars in Oncology|August 12, 2009
Epithelioid soft tissue tumorsA Paolo Dei Tos, Andrew J Wagner, Piergiorgio Modena, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Changing concepts in the pathological basis of soft tissue and bone sarcoma treatmentPancras C W Hogendoorn, Françoise Collin, Søren Daugaard, et al.
Seminars in Oncology|August 12, 2009
Small round cell sarcomasStephen L Lessnick, A Paolo Dei Tos, Poul H B Sorensen, et al.
The Lancet. Oncology|March 13, 2014
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trialIan Judson, Jaap Verweij, Hans Gelderblom, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Seminars in Oncology|August 12, 2009
Epithelioid soft tissue tumorsA Paolo Dei Tos, Andrew J Wagner, Piergiorgio Modena, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Changing concepts in the pathological basis of soft tissue and bone sarcoma treatmentPancras C W Hogendoorn, Françoise Collin, Søren Daugaard, et al.
Seminars in Oncology|August 12, 2009
Small round cell sarcomasStephen L Lessnick, A Paolo Dei Tos, Poul H B Sorensen, et al.
The Lancet. Oncology|March 13, 2014
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trialIan Judson, Jaap Verweij, Hans Gelderblom, et al.
Pageof 1